Targeting occult tumor cell dissemination in localized breast cancer
- Prosjektnummer
- 2008137
- Ansvarlig person
- Bjørn Naume
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Nytt flerårig forskningsprosjekt
- Helsekategori
- Forskningsaktivitet
Allele-specific copy number analysis of tumors.
Proc Natl Acad Sci U S A 2010 Sep;107(39):16910-5. Epub 2010 sep 13
PMID: 20837533
Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis.
J Clin Oncol 2010 Sep;28(27):4129-34. Epub 2010 aug 16
PMID: 20713855
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.
Sci Transl Med 2010 Jun;2(38):38ra47.
PMID: 20592421
NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.
Mol Cancer 2010;9():113. Epub 2010 mai 19
PMID: 20482849
Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.
Histol Histopathol 2009 Aug;24(8):1049-59.
PMID: 19554512
A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide.
Clin Cancer Res 2009 Jun;15(12):4165-73. Epub 2009 jun 9
PMID: 19509150
Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation.
Nucleic Acids Res 2009 Jul;37(12):e89. Epub 2009 mai 27
PMID: 19474344
The prognostic impact of occult nodal metastasis in early breast carcinoma.
Breast Cancer Res Treat 2009 Nov;118(1):57-66. Epub 2009 feb 15
PMID: 19219629
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
J Pathol 2008 Feb;214(3):357-67.
PMID: 18044827
Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients.
Genes Chromosomes Cancer 2008 Aug;47(8):680-96.
PMID: 18398821
Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination.
Clin Cancer Res 2008 Apr;14(8):2341-50.
PMID: 18413823
Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors.
BMC Genomics 2008;9():379. Epub 2008 aug 8
PMID: 18691401
Array Comparative Genomic Hybridization (aCGH) differentiates the major Intrinsic Subgroups of Breast Carcinomas.
EACR 2010 (26.-29. June).Abstract - poster presentation
Molecular signatures of long non-coding RNAs in breast cancer patients.
EACR 2010 (26.-29. June)Abstract - poster presentation
Genomic profiles of disseminated tumor cells in metastatic breast cancer patients.
EACR 2010 (26.-29. June) Abstract - poster presentation
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
Breast Cancer Res Treat. Epub 2010 May 7 (publisert endelig februar 2011). Original publikasjon.
Molecular signatures of disseminated tumor cells in metastatic breast cancer patients.
Joint ECCO 15/ESMO34 Berlin 20.-24. September 2009. Abstract P-1096. Poster presentation
Genomic profiles of disseminated tumor cells in metastatic breast cancer patients.
7th International Symposium on Minimal Residual Disease. September 16.-19. 2009. Abstract no O19. Oral presentation.
Minimal Residual Disease.
Breast Surgical Oncology. Kuerer's. Chapter 27. Pages 297-306. 2009.
Comparison and combination of gene-set classifiers for prediction of localized breast cancer survival.
Joint ECCO 15/ESMO34 Berlin 20.-24. September 2009. Abstract P-5169. Poster presentation
Clinical relevance of early disseminated breast cancer cells depends on their cytokeratin expression pattern.
International Symposium on Minimal Residual Disease. September 16.-19. 2009. Abstract no P15. Poster presentation.
A QPCR-based circulating tumor cell detection platform predicts survival in breast cancer patients.
7th International Symposium on Minimal Residual Disease. September 16.-19. 2009. Abstract no P11. Poster presentation.
Performance of adnatest for CTC detection in breast cancer patients. Comparison to other CTC detection methods.
7th International Symposium on Minimal Residual Disease. September 16.-19. 2009. Abstract no P10. Poster presentation.
A QPCR-based circulating tumor cell detection platform predicts survival in 776 early stage breast cancer patients.
32rd annual San Antonio Breast Cancer Symposium 9.-13.Dec 2009. Abstract. Poster presentation
Objective measurements of complex genomic rearrangements using a novel algorithm CAAI give indep.progn. inform. in Breast Cancer
AACR Breast 2009 Poster presentation
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport